Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$552.4M
-5.3% from 2023
Prescriptions
18.6M
$29.73 per claim
Patients
6.7M
564,074 prescribers
Total spending, 2024
$552.6M
$82.50 per patient
Medicare prescription drug plans paid $552.4M for Albuterol Sulfate Hfa in 2024, for 18,584,536 prescriptions and refills to 6,695,723 patients (down 5.3% from 2023). The average cost per claim was $29.73.
California had the highest Medicare cost for Albuterol Sulfate Hfa in 2024: $49.6M for 1,733,963 claims, followed by New York ($45.2M).
Jorge Sanchez-Masiques, pulmonary disease in Miami, FL, had the highest Medicare cost for Albuterol Sulfate Hfa in 2024: 17,876 claims costing $451K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 17,876 | 3,454 | $451K |
| Reuven Moshenyat Brooklyn, NY | Pulmonary Disease | 5,796 | 1,257 | $180K |
| Carissa M Cruz Berrios |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 525,387 | 15,043,894 | 5,655,042 | $710.6M |
| 2023 | 544,847 | 16,607,172 | 6,123,602 | $583.6M |
| 2024 | 564,074 | 18,584,536 | 6,695,723 | $552.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 3,327 |
| 954 |
| $144K |
| Huan A Le San Diego, CA | Pulmonary Disease | 4,440 | 837 | $125K |
| Juan C Acevedo-Crespo Coral Gables, FL | Pulmonary Disease | 4,496 | 1,166 | $125K |
| Armando O Cardona-Ramirez Mayaguez, PR | Pulmonary Disease | 2,731 | 563 | $121K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 4,663 | 1,139 | $114K |
| Elsie M Diaz - Schroeder Caguas, PR | Pulmonary Disease | 2,408 | 534 | $103K |
| Hany S Aziz Bakersfield, CA | Pulmonary Disease | 3,295 | 902 | $103K |
| Odette L Campbell Plano, TX | Internal Medicine | 1,678 | 463 | $103K |
| Juan J Candelario Lanza Caguas, PR | Pulmonary Disease | 2,432 | 557 | $103K |
| Domingo Chardon Ponce, PR | Pulmonary Disease | 2,352 | 688 | $101K |
| Jesus M Roman Mayaguez, PR | Pulmonary Disease | 2,054 | 448 | $90K |
| Chitra Kandaswamy Fresno, CA | Pulmonary Disease | 2,848 | 1,028 | $84K |
| Luis F Velez-Quinones Arecibo, PR | Internal Medicine | 1,975 | 640 | $83K |
| Luis C Torrellas Ruiz Humacao, PR | Pulmonary Disease | 1,673 | 414 | $80K |
| Andres A Redondo Miami, FL | Pulmonary Disease | 3,000 | 737 | $78K |
| Juan C Buitrago Guayama, PR | Internal Medicine | 1,739 | 469 | $76K |
| Rosangela L Fernandez Medero Caguas, PR | Pulmonary Disease | 1,601 | 426 | $75K |
| Juan C Rodriguez Pembroke Pines, FL | Pulmonary Disease | 1,373 | 550 | $74K |
| Samer Alkhuja East Stroudsburg, PA | Pulmonary Disease | 1,606 | 479 | $73K |
| Jahaira L Serrano Dominguez Arecibo, PR | Pulmonary Disease | 1,538 | 652 | $73K |
| Kenneth K Sha Flushing, NY | Pulmonary Disease | 2,796 | 744 | $72K |
| Samuel Suarez Baez San Juan, PR | Pulmonary Disease | 1,782 | 623 | $72K |
| Sergio Martinez Jackson Heights, NY | Pulmonary Disease | 2,124 | 607 | $70K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Prasco Labs | 4,575,425 | $190.7M |
| Lupin Pharmaceu LUPIN.NS | 4,624,391 | $133.2M |
| Teva USA TEVA | 4,231,623 | $110.9M |
| Cipla USA, Inc. CIPLA.NS | 2,577,963 | $60.9M |
| Sandoz SDZ.SW | 1,416,581 | $29.8M |
| West-Ward/Hikma HIK.L | 1,134,311 | $26.4M |
| Perrigo/Padagis PRGO | 13,120 | $346K |
| Armstrong Pharm | 11,023 | $225K |
| AHP | 4,631 | $97K |
| Exelan Pharmace | 2,424 | $21K |
| Civica, Inc. | 113 | $1,446 |